Using the level of anti-ENO1 Ab and the number of Treg cells in patients as surrogate indicators, the reversion of immunosuppressive status was observed in most NSCLC patients after curative-intension surgery in this study. The gene discussed is ENO1; the disease is non-small cell lung carcinoma.